Spots Global Cancer Trial Database for Outcome of Dental Implant Therapy in Patients Treated With Antiresorptive Medication
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Outcome of Dental Implant Therapy in Patients Treated With Antiresorptive Medication
Official Title: Outcome of Dental Implant Therapy in Patients Treated With Antiresorptive Medication
Study ID: NCT04741906
Study Description
Brief Summary: Aim of the study is to examine the feasibility of dental implant insertion in patients receiving high, adjuvant and low dose \> 4 years.
Detailed Description: The hypothesis of the present study is that dental implant therapy using submerged healing is feasible and predictable in patients receiving high, adjuvant or low dose AR for more than 4 years, as documented by clinical and radiographic signs of osseointegration after 3-4 months, sufficient implant stability for abutment connection, and implant survival rates comparable to those of healthy individuals after one year of prosthetic loading.
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Copenhagen University Hospital, Maxillofacial Department, Copenhagen, Danmark, Denmark
Contact Details
Name: Sanne Werner Moeller Andersen, DDS
Affiliation: Copenhagen University Hospital, Maxillofacial surgery
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
